메뉴 건너뛰기




Volumn 242, Issue 1589, 1998, Pages 577-586

Heart disease in older patients

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EID: 0032130187     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (10)
  • 1
    • 0022469583 scopus 로고
    • Randomised trial of treatment of hypertension in elderly patients in primary care
    • Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986;293:1145-1151
    • (1986) BMJ , vol.293 , pp. 1145-1151
    • Coope, J.1    Warrender, T.S.2
  • 2
    • 0026512315 scopus 로고
    • Medical Research Council trial of treatment of hypertension in older adults
    • MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults. BMJ 1992;304:405-412
    • (1992) BMJ , vol.304 , pp. 405-412
  • 3
    • 0000220739 scopus 로고
    • Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
    • SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-3261
    • (1991) JAMA , vol.265 , pp. 3255-3261
  • 4
    • 0025942936 scopus 로고
    • Morbidity and mortality in the Swedish trial of old patients with hypertension
    • Dahlof B, Lindholm LH, Hansson L et al. Morbidity and mortality in the Swedish trial of old patients with hypertension. Lancet 1991;338:1281-1285
    • (1991) Lancet , vol.338 , pp. 1281-1285
    • Dahlof, B.1    Lindholm, L.H.2    Hansson, L.3
  • 5
    • 0021864792 scopus 로고
    • Morbidity and mortality results from the European Working Party in High Blood Pressure in the Elderly trial
    • Amery A, Brixko P, Clement D et al. Morbidity and mortality results from the European Working Party in High Blood Pressure in the Elderly trial. Lancet 1985;i:1349-1354
    • (1985) Lancet , vol.1 , pp. 1349-1354
    • Amery, A.1    Brixko, P.2    Clement, D.3
  • 6
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
    • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1991;344:1383-1389
    • (1991) Lancet , vol.344 , pp. 1383-1389
  • 7
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 8
    • 0023266532 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure
    • The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435
    • (1987) N Engl J Med , vol.316 , pp. 1429-1435
  • 9
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular disfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial
    • Pfeffer MA. Braunwald E, Moye LA et al. for the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular disfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327.669-677
    • (1992) N Engl J Med , vol.327 , pp. 669-677
    • Pfeffer, M.A.1    Braunwald, E.2    Moye, L.A.3
  • 10
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials
    • Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagualtion Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Non-rheumatic Atrial Fibrillation Study
    • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagualtion Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Non-rheumatic Atrial Fibrillation Study. Arch Intern Med 1994;154:1449-1457
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.